Trial Profile
A Single-centre, Open-label Study in Healthy Adult Volunteers to Determine the Effects of Multiple-dose Omeprazole (ANTRA® 40 mg qd) on the Single-dose Pharmacokinetics of Tipranavir 500 mg Coadministered With Ritonavir 200 mg
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Oct 2014
Price :
$35
*
At a glance
- Drugs Tipranavir (Primary) ; Omeprazole; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 09 Oct 2014 New trial record